Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 08/26 10:16:38 am
1644 GBp   -0.54%
08/25 GLAXOSMITHKLINE : GSK) Unveils Take 5 for Meningitis
08/25 INSIDE THE FDA : Frontrunners Merck & Co., Inc. (NYSE:MRK), GlaxoSm..
08/22 UK dividends lagging behind UK
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Sales26 50523 00623 92326 81528 15929 296
Operating income (EBITDA)8 8838 0457 0289 1199 69110 223
Operating profit (EBIT)8 0156 5945 7297 2647 8258 427
Pre-Tax Profit (EBT)6 6472 96810 5264 0175 8116 691
Net income5 6282 7568 4222 6823 9804 748
P/E ratio14,624,37,9735,121,818,7
EPS (GBp )11156,717247,076,088,6
Dividend per Share (GBp )78,080,080,080,080,080,9
Yield4,84%5,81%5,83%4,84%4,84%4,89%
Reference price (GBp )1611.513761373165316531653
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Debt12 64514 37710 72713 19522 77912 152
Finance------
Operating income (EBITDA)8 8838 0457 0289 1199 69110 223
Leverage
(Debt/EBITDA)
1,42x1,79x1,53x1,45x2,35x1,19x
Capital Expenditure1 1881 1881 3801 6651 5681 565
Book Value Per Share (BVPS)146 PNC87,6 PNC106 PNC72,0 PNC57,4 PNC84,7 PNC
Cash Flow per Share149 PNC108 PNC53,2 PNC108 PNC137 PNC143 PNC
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 80 580 M GBP -
Entreprise Value (EV) 93 775 M GBP 103 359 M GBP
Valuation 2016e 2017e
P/E ratio (Price / EPS) 35,1x 21,8x
Capitalization / Revenue 3,00x 2,86x
EV / Revenue 3,50x 3,67x
EV / EBITDA 10,3x 10,7x
Yield (DPS / Price) 4,84% 4,84%
Price to book (Price / BVPS) 22,9x 28,8x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 27,1% 27,8%
operating Leverage (Delta EBIT / Delta Sales) 2,22x 1,54x
Net Margin (Net Profit / Revenue) 10,0% 14,1%
ROA (Net Profit / Asset) 7,81% 9,53%
ROE (Net Profit / Equities) 79,8% 119%
Rate of Dividend 170% 105%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   6,21% 5,57%
Cash Flow / Sales 19,7% 23,7%
Capital Intensity (Assets / Sales) 1,28x 1,48x
Financial Leverage (Net Debt / EBITDA) 1,45x 2,35x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend